Industry Briefs: December 3, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
AMRI will close its Bothell, Washington, site, and transition the site’s drug-discovery capabilities to Singapore while certain analytical capabilities will consolidate into the company’s analytical quality group in Albany, New York. Read More
Aptiv Solutions has opened a new laboratory and office in Durham, North Carolina. Read More
Bend Research, PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) have developed a new technology for the production of thermostable vaccines. Read More
biOasis Technologies has entered into a research collaboration agreement with UCB to evaluate biOasis’s Transcend technology in the area of the delivery of therapeutic compounds to the brain. Read More
Capsugel has doubled its laboratory capacity with the opening of its new quality-control laboratory in Greenwood, South Carolina. Read More
Covance’s early-development facility in Shanghai, China, has received a Good Laboratory Practice Certificate from China’s State Food and Drug Administration. Read More
Dalton Pharma Services has added size-exclusion chromatography (SEC) - multi angle (laser) light-scattering (MALS) large-molecule testing services. Read More
Galena Biopharma has signed an agreement with a subsidiary of Teva Pharmaceutical Industries for the commercialization of NeuVax (nelipepimut-S or E75) in Israel. Read More
Hovione and Solvias have announced a collaboration focused on the development and GMP supply of pharmaceutical cocrystals. Read More
NextPharma has completed the sale of its Bioserv, its US affiliate, to KESA Partners. Read More
Noven Pharmaceuticals has acquired commercial rights to Minivelle (estradiol transdermal system) in the US and Canada. Read More
Recipharm has invested to expand its capacity in analytical services and stability studies at its facility in Solna, Sweden. Read More
Single Cell Technology and Open Monoclonal Technology have announced a human antibody discovery and development collaboration. Read More
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
